Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 1.52% vs -9.36% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 314.72% vs -89.68% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -1.88% vs -44.22% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 228.87% vs -87.00% in Mar 2024
Compare Profit and Loss Results of Samrat Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
285.00
46.00
239.00
519.57%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
285.00
46.00
239.00
519.57%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
0.00
-2.00
0%
Raw Materials Consumed
269.00
4.00
265.00
6,625.00%
Power & Fuel Cost
1.00
3.00
-2.00
-66.67%
Employee Cost
2.00
11.00
-9.00
-81.82%
Operating Expenses
2.00
0.00
2.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
275.00
25.00
250.00
1,000.00%
Operating Profit (PBDIT) excl Other Income
10.00
20.00
-10.00
-50.00%
Other Income
0.00
4.00
-4.00
-100.00%
Operating Profit (PBDIT)
11.00
25.00
-14.00
-56.00%
Interest
0.00
7.00
-7.00
-100.00%
Profit before Depriciation and Tax
10.00
18.00
-8.00
-44.44%
Depreciation
0.00
9.00
-9.00
-100.00%
Profit Before Taxation & Exceptional Items
9.00
9.00
0.00
0.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
9.00
9.00
0.00
0.00%
Provision for Tax
2.00
1.00
1.00
100.00%
Profit After Tax
7.00
7.00
0.00
0.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
61.00
21.00
40.00
190.48%
Profit Available for appropriations
69.00
29.00
40.00
137.93%
Appropriations
69.00
29.00
40.00
137.93%
Equity Dividend (%)
10%
0%
10.00
Earnings Per Share
23.02
4.95
18.07
365.05%
Profit And Loss - Net Sales
Net Sales 285.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 1.52% vs -9.36% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.24 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 314.72% vs -89.68% in Mar 2024
Profit And Loss - Interest
Interest 0.67 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.88% vs -44.22% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 7.11 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 228.87% vs -87.00% in Mar 2024
